Stocktoria
ANI PHARMACEUTICALS INC ANIP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-05-04
ANI PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 12.6% | 0.1% | 9.6% | -11.2% | -18.4% |
| Net margin | 8.9% | -3.0% | 3.9% | -15.1% | -19.7% |
| FCF margin | 19.4% | 7.8% | 22.6% | -12.7% | 0.4% |
| Return on assets | 5.4% | -1.4% | 2.1% | -6.3% | -5.5% |
| Return on equity | 14.5% | -4.6% | 4.3% | -15.3% | -12.8% |
| Debt / equity | 0.54× | 0.77× | 0.66× | 0.91× | 0.86× |
| Current ratio | 2.71 | 2.72 | 3.57 | 3.46 | 3.68 |
| Revenue growth | 43.8% | 26.2% | 53.9% | 46.4% | 3.7% |
Source: SEC EDGAR filings · CIK 0001023024 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.